Rosuvastatin
ID03-51-15
Approved small_molecule active
Quick answer
Rosuvastatin for Systemic Lupus Erythematosus is a Approved program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Systemic Lupus Erythematosus
- Phase
- Approved
- Modality
- small_molecule
- Status
- active